Straumann and Anthogyr announce partnership

Straumann, a global leader in tooth replacement solutions, and the French dental implant manufacturer Anthogyr have announced a partnership agreement that enables the Swiss company to invest in Anthogyr and to address a broader section of the fast-growing tooth replacement market in China.

Anthogyr’s dental implant system is registered and established in China where it is positioned as a high-quality attractively-priced option. The agreement foresees the transfer of Anthogyr’s implantology business activities in China to Straumann by mid-year, giving the latter access to the fast-growing value segment there. The combination of the two companies’ sales capabilities is expected to provide the critical mass to compete and grow successfully in this segment. Straumann already leads the premium segment in China and has recently established a new country organization and distributor network covering all provinces.

In addition, Straumann is to acquire a 30% stake in Anthogyr and offers potential leverage to the business in other markets through Instradent, the business platform that Straumann is building to address the global value segment with multiple brands. Financial details were not disclosed and the agreement is expected to become effective at the end of March, subject to the fulfilment of certain conditions.

About Anthogyr

Located in Sallanches, France, Anthogyr is a family-owned business rooted in the precision engineering region close to Geneva. Anthogyr began manufacturing dental implants in 1980 and has expanded rapidly in recent years boosted by the success of its Axiom implant system. With a team of 400 employees and consolidated sales of approximately 45 million euros, the company develops, manufactures its products in France and Luxemburg and sells them on five continents through eight subsidiaries and a network of distributors. Almost 60% of its sales are in its domestic market, 15% elsewhere in Europe and approximately 15% in Asia.

About Straumann

Headquartered in Basel, Switzerland, Straumann (SIX: STMN) is a global leader in implant, restorative and regenerative dentistry. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and biomaterials for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately 3450 people worldwide and its products and services are available in more than 100 countries through its broad network of distribution subsidiaries and partners.